Asianet NewsableAsianet Newsable

Indian travellers fully vaccinated with Covaxin can now enter US from Nov 8

According to the latest travel rules, the US will also accept travellers fully vaccinated with Pfizer-BioNTech, Johnson & Johnson, Moderna, Oxford-AstraZeneca, Covishield, Sinopharm and Sinovac.
 

Indian travellers fully vaccinated with Covaxin can now enter US from Nov 8-dnm
Author
Washington D.C., First Published Nov 4, 2021, 11:11 AM IST
  • Facebook
  • Twitter
  • Whatsapp

After WHO recommended the Emergency Use Listing status for Covaxin, the United States updated its list of approved vaccines and gave a green signal to travellers vaccinated with Bharat Biotech's Covaxin to enter the country from November 8, when it is all set to open its borders to vaccinated foreign travellers.

Updating the approved travel list for Covaxin, CDC press officer Scott Pauley told ANI that US’ travel guidelines apply to FDA approved WHO Emergency Listed vaccines. CDC’s travel guidance applies to FDA approved or authorized and WHO Emergency Use Listing vaccines and encompasses any new vaccines that may be added to either of those lists over time, he said.

The latest addition to travel guidelines comes less than a week before the US launches its new travel system, which allows foreign travellers who have received a vaccine that has been approved for emergency use by WHO or the US Food and Drug Administration (FDA) to enter the country.

Also read: Coronavirus: India logs 12,885 new cases, 8% higher than yesterday; active caseload falls below 1.5 lakh

The US will also accept travellers fully vaccinated with Pfizer-BioNTech, Johnson & Johnson, Moderna, Oxford-AstraZeneca, Covishield, Sinopharm and Sinovac, according to the latest travel rules.

Ending the historic restrictions that had barred much of the world from entering the United States for as long as 21 months, the White House on October 16 had announced it will lift Covid-19 travel restrictions for fully vaccinated international visitors starting November 8. 

Covaxin, developed by Bharat Biotech was acknowledged by the US Centre for Disease Control (CDC) yesterday after the WHO granted emergency use listing. “WHO has granted emergency use listing (EUL) to #COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of Covid-19," the UN health body said in a tweet on Wednesday.

Follow Us:
Download App:
  • android
  • ios